Using nominal group technique to identify barriers and facilitators to preventing HIV using combination same-day pre-exposure prophylaxis and medications for opioid use disorder
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7517
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Using nominal group technique to identify barriers and facilitators to preventing HIV using combination same-day pre-exposure prophylaxis and medications for opioid use disorder ; volume:19 ; number:1 ; day:28 ; month:10 ; year:2022 ; pages:1-11 ; date:12.2022
Harm reduction journal ; 19, Heft 1 (28.10.2022), 1-11, 12.2022
- Creator
-
Eger, William H.
Altice, Frederick L.
Lee, Jessica
Vlahov, David
Khati, Antoine
Osborne, Sydney
Wickersham, Jeffrey A.
Bohonnon, Terry
Powell, Lindsay
Shrestha, Roman
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12954-022-00703-8
- URN
-
urn:nbn:de:101:1-2023011321164699687988
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Eger, William H.
- Altice, Frederick L.
- Lee, Jessica
- Vlahov, David
- Khati, Antoine
- Osborne, Sydney
- Wickersham, Jeffrey A.
- Bohonnon, Terry
- Powell, Lindsay
- Shrestha, Roman
- SpringerLink (Online service)
Other Objects (12)
Pre-Exposure Prophylaxis (PrEP)
P41 - Preexposure prophylaxis of infants’ food allergy
HIV Pre-exposure Prophylaxis in Germany: Barriers and Strategies to Improve Uptake
Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities
Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns
Pre-exposure prophylaxis against HIV: pros and cons
Correction to: Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
A Review of HIV Pre-exposure Prophylaxis Streamlining Strategies
Post-trial access to and use of pre-exposure prophylaxis in Durban, South Africa
Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany
A qualitative study identifying implementation strategies using the i-PARIHS framework to increase access to pre-exposure prophylaxis at federally qualified health centers in Mississippi
Awareness of, willingness to use, and experiences with Pre-exposure prophylaxis among youth in Nigeria
Pre-Exposure Prophylaxis (PrEP)
P41 - Preexposure prophylaxis of infants’ food allergy
HIV Pre-exposure Prophylaxis in Germany: Barriers and Strategies to Improve Uptake
Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities
Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns
Pre-exposure prophylaxis against HIV: pros and cons
Correction to: Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
A Review of HIV Pre-exposure Prophylaxis Streamlining Strategies
Post-trial access to and use of pre-exposure prophylaxis in Durban, South Africa
Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany
A qualitative study identifying implementation strategies using the i-PARIHS framework to increase access to pre-exposure prophylaxis at federally qualified health centers in Mississippi
Awareness of, willingness to use, and experiences with Pre-exposure prophylaxis among youth in Nigeria
Pre-Exposure Prophylaxis (PrEP)
P41 - Preexposure prophylaxis of infants’ food allergy
HIV Pre-exposure Prophylaxis in Germany: Barriers and Strategies to Improve Uptake
Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities
Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns
Pre-exposure prophylaxis against HIV: pros and cons
Correction to: Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
A Review of HIV Pre-exposure Prophylaxis Streamlining Strategies
Post-trial access to and use of pre-exposure prophylaxis in Durban, South Africa
Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany
A qualitative study identifying implementation strategies using the i-PARIHS framework to increase access to pre-exposure prophylaxis at federally qualified health centers in Mississippi